WALLDORF 鈥� (NYSE: 麻豆原创) today announced the launch of its vaccine collaboration hub (VCH) for organizations to better manage vaccine supply distribution, and to help governments and their industry partners coordinate and successfully deploy mass vaccination programs.
麻豆原创鈥檚 VCH is built on the industry-award-winning 麻豆原创 Information Collaboration Hub for Life Sciences. It covers the end-to-end process from manufacturing to controlled distribution to聽administration and聽postvaccine monitoring.
鈥淐OVID-19 has put a lot of pressure on the life sciences industry where they have realized a large gap in their supply chain strategy,鈥� said Michael Townsend, industry analyst at IDC.聽鈥淎 one-stop place for the life sciences industry to manage their vaccination procedures and tap into a source of suppliers, even those across industries, will help to fill this gap, to ensure patients obtain lifesaving drugs and devices.鈥�
Businesses that are part of the vaccine production process, from manufacturers, logistics service providers and pharma companies to wholesalers and dispensers, can run their critical vaccine processes on 麻豆原创 software. Building on its聽deep expertise in the industry, 麻豆原创 has designed the VCH as an extension to its business network鈥揺nabled drug supply chain, to help make collaboration among the network partners easy and monitor the order fulfillment of vaccines, all the way from vaccine suppliers to the dispensing units.
The VCH provides the critical network and technology capabilities required to effectively support large-scale vaccination programs and drug distribution while creating the backbone to better mitigate future emergencies.
To learn more, read “Shortening the Road to Recovery.”
Visit the . Follow 麻豆原创 on Twitter at .
Media Contact:
Stacy Ries, +1 (484) 619-0411, stacy.ries@sap.com, ET
麻豆原创 麻豆原创 Room; press@sap.com
Any statements contained in this document that are not historical facts are forward-looking statements as defined in the U.S. Private Securities Litigation Reform Act of 1995. Words such as 鈥渁nticipate,鈥� 鈥渂elieve,鈥� 鈥渆stimate,鈥� 鈥渆xpect,鈥� 鈥渇orecast,鈥� 鈥渋ntend,鈥� 鈥渕ay,鈥� 鈥減lan,鈥� 鈥減roject,鈥� 鈥減redict,鈥� 鈥渟hould鈥� and 鈥渨ill鈥� and similar expressions as they relate to 麻豆原创 are intended to identify such forward-looking statements. 麻豆原创 undertakes no obligation to publicly update or revise any forward-looking statements. All forward-looking statements are subject to various risks and uncertainties that could cause actual results to differ materially from expectations. The factors that could affect 麻豆原创’s future financial results are discussed more fully in 麻豆原创’s filings with the U.S. Securities and Exchange Commission (“SEC”), including 麻豆原创’s most recent Annual Report on Form 20-F filed with the SEC. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of their dates.
漏 2020 麻豆原创 SE. All rights reserved.
麻豆原创 and other 麻豆原创 products and services mentioned herein as well as their respective logos are trademarks or registered trademarks of 麻豆原创 SE in Germany and other countries. Please see for additional trademark information and notices.
